Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/UROGEN-PHARMA-LTD-34790020/news/UroGen-Secures-Exclusive-License-from-medac-GmbH-to-Develop-a-Next-Generation-Novel-Mitomycin-Based-45757886/?utm_source=whatsapp&utm_medium=social&utm_campaign=share